Found "AI": 1,144 results
Addressing Antimicrobial Resistance in Thailand: A Policy Overview
Antimicrobial Resistance (AMR) occurs when pathogens (bacteria, viruses, fungi, and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR has been increasing in low-, middle- and high-income
Which investment on interventions against COVID-19 pandemic is worth its cost?
Various public health measures have been taken by governments and health authorities to prevent and control pandemics across time. The benefit of investing in any health condition should outweigh the costs of not investing in it. The objective of this evidence brief to review studies conducted
Antimicrobial Resistance Policy in Thailand
AMR occurs when pathogens (bacteria, viruses, fungi and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR is a natural phenomenon, however the speed at which it occurs is impacted by how
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed.
The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro
Towards A Sustainable Kidney Replacement Therapy Program: Recommendations For Thailand’s 2022 Dialysis Reform
The National Health Security Office Working Group (NHSO WG) conducted structured, evidence-based deliberations to generate recommendations for the National Health Security Board on the kidney replacement therapy (KRT) policy.
These are the proposed recommendations:
To consider defining KRT p
Health Financing during COVID-19 responses in Thailand
Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID-19 tests, treatments, and vaccination services.
In addition to having higher hospital reserves than in the pre-pandemic period, private hospital
Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access
MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations.
The a
Unveiling Thailand’s Path to Open Data for Health Policy
Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development.
These open data movements observed during
Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes.
This study marks the first global eco
Hospitals Fear Cuts in Aid for Care to Illegal Immigrants
President Obama’s health care law is putting new strains on some of the nation’s most hard-pressed hospitals, by cutting aid they use to pay for emergency care for illegal immigrants, which they have long been required to provide.The federal government has been spending $20 billion annually to reimb
10 / Page